Patient FAQs | Eversense CGM

Your Questions, Answered

We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.

Filter by topic:

Lithotripsy (Therapeutic Ultrasound) – The use of lithotripsy is not recommended for people who have an inserted sensor because the effects are unknown. DO NOT use lithotripsy near the sensor.

Diathermy:

DO NOT use diathermy on people who have an inserted sensor. Energy from the diathermy can transfer through the sensor and cause tissue damage in the insertion area.

Electrocautery:

The use of electrocautery near the inserted sensor may damage the device. DO NOT use electrocautery near the sensor.

We are limited to how much we can troubleshoot questions regarding the Apple Health app, however, I can provide you with the website and phone number of Apple support.

Website: support.apple.com Tollfree: 1-800-MY-APPLE

DO NOT insert your infusion set within 4 inches (10.16 cm) of the sensor site. If the insulin delivery site is within 4 inches (10.16 cm) of the sensor site, it may interfere with sensor glucose readings and can cause inaccurate glucose readings.

There is a 3-hour delay in glucose data going from your Eversense^® CGM into Apple Health. The Eversense^® CGM App on your smart phone should be your primary device for monitoring your glucose levels and for making treatment decisions in real time.

X-ray, CT Scan:

DO NOT wear the smart transmitter during medical x-rays or computed tomography (CT) scans. To avoid interference with results, remove the smart transmitter before undergoing medical x-ray or CT scans. Make sure your health care professional knows about your smart transmitter.

Eversense^® 365 Sensor is manufactured by Senseonics across the US and Europe.

Eversense^® 365 Transmitter is manufactured by Senseonics in Minnesota, USA.

Still have questions?

The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.

The Eversense^® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied. 

Apple Watch^® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

MKT-001692 Rev 1

Your Questions, Answered

Still have questions?

Pre-Qualify for Eversense 365

Thanks! We've got your info. You may be eligible for Eversense 365

Thanks! We've got your info.

I'M JUST RESEARCHING

I'M READY NOW!

Contact Information

Preferred Language

Your Questions, Answered

Lithotripsy, Diathermy, Electrocautery

Why is my time in range [or any other statistic] different on my Apple Health app than on my Eversense® App?

How close can an insulin pump infusion set be to the Eversense® 365 Sensor location?

Why does my glucose data in Apple Health look delayed?

CT-Scan, X-Ray

Where is Eversense® manufactured?

Still have questions?

I'M JUST RESEARCHING

I'M READY NOW!